Investor and Entrepreneur
Louisville , KY
CEO at Sheltowee Network
Science and technology, entrepreneurism and the outdoors.
Love the Lord your God with all your heart and love your neighbor as yourself.
I founded Kentucky Bioprocessing that developed the first vaccine to treat Ebola after someone was exposed to it. We saved the lives of American healthcare workers who were exposed to Ebola with the vaccine.
I love the outdoors. In 1996 I went to Africa and climbed Kilimanjaro. Glacier National Park is one of my favorite places in the world.
My strengths are in strategic planning, business development and technical diligence. I really enjoy working with entrepreneurs and scientists who are driven by a desire to make the world a better place. I look for people who are passionate, highly ethical, talented and driven.
Alex Day's educational background is in physics, mathematics and Russian Language. He studied at Western Kentucky University and the Leningrad Polytechnic Institute. He founded Sheltowee in 2000 and has managed multiple venture capital funds and has helped start dozens of companies. In 2005 Alex developed the business plan and helped found Kentucky BioProcessing. He recruited the scientific team that developed a vaccine for Ebola that was effective post exposure and expressed in tobacco. Alex has helped to raise over $100 million for various companies and currently leads the Sheltowee Network.